Conference Coverage

Skipping breakfast triggers acute insulin resistance

Publish date: June 17, 2013

 

AT ENDO 2013

Dr. Thomas reported having no financial disclosures. The study was funded by the Endocrine Fellows Foundation, the National Institutes of Health, and the Colorado Nutrition Obesity Research Center.

sboschert@frontlinemedcom.com

On Twitter @sherryboschert

Pages

Recommended Reading

DEA scheduling brings weight-loss drug closer to market
MDedge Endocrinology
Fewer nocturnal hypoglycemia episodes with insulin degludec
MDedge Endocrinology
Type 2 diabetics often harbor undiagnosed heart failure
MDedge Endocrinology
Metformin appears to be associated with reduced colorectal cancer risk
MDedge Endocrinology
Gastric bypass helps poorly controlled type 2 diabetes
MDedge Endocrinology
FDA panel starts review of rosiglitazone CV data
MDedge Endocrinology
FDA panel supports easing rosiglitazone restrictions
MDedge Endocrinology
Serious hypoglycemic events doubled dementia risk in diabetes
MDedge Endocrinology
Medicare uses more brand-name drugs than does VA
MDedge Endocrinology
FDA panels revisit rosiglitazone's cardiovascular safety
MDedge Endocrinology